BCM
ACHV icon

Bridgeway Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Bridgeway Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-98
Closed -$261K – 1430
2015
Q4 		$261K Hold
98
– – ﹤0.01% 1240
2015
Q3 		$481K Hold
98
– – 0.01% 1050
2015
Q2 		$502K Hold
98
– – 0.01% 1076
2015
Q1 		$463K Buy
+98
New +$481K 0.01% 1125

Other funds holding ACHV

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Bridgeway Capital Management's ACHV Position: Q1 2016 in Review

Bridgeway Capital Management sold out of Achieve Life Sciences (ACHV) in Q1 2016, closing a stake of 98 shares — an estimated $261K sold.

Bridgeway Capital Management first reported a position in ACHV in Q1 2015 and held it in 4 quarters. The position peaked at $502K in Q2 2015. 38 funds tracked by Wall St. Rank hold ACHV as of Q1 2016.

  • Bridgeway Capital Management reported no remaining Achieve Life Sciences position as of Q1 2016 after selling out during the quarter.
  • Bridgeway Capital Management sold 98 Achieve Life Sciences shares in Q1 2016, an estimated $261K.
  • Bridgeway Capital Management first reported a position in Achieve Life Sciences in Q1 2015 and held it in 4 quarters.
  • Bridgeway Capital Management's Achieve Life Sciences position peaked at $502K in Q2 2015.
  • 38 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2016.

Based on Bridgeway Capital Management's 13F filing for Q1 2016, filed 16 May 2016.